
Regonat contains Regorafenib 40 mg, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Generic Name | Regorafenib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Colorectal Cancer, Liver Cancer and GIST |
| Availability | In Stock |




As a leading supplier of high-quality generic anticancer medicines, we provide Regonat (Regorafenib 40mg) tablets, widely used for the treatment of colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
We ensure safe, consistent, and timely bulk supply of oncology drugs, including Regorafenib (Generic Stivarga), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.